PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors

Added 162 days ago (19.05.2021)
Authors: Roberta Minari; Francesco Bonatti; Giulia Mazzaschi; Alessandra Dodi; Francesco Facchinetti; Francesco Gelsomino; Gloria Cinquegrani; Anna Squadrilli; Paola Bordi; Sebastiano Buti; Melissa Bersanelli; Alessandro Leonetti; Agnese Cosenza; Leonarda Ferri; Elena Rapacchi; Federico Quaini; Andrea Ardizzoni; Marcello Tiseo
Journal: Tumori
Read article